Ky. Hung et al., Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo, KIDNEY INT, 59(6), 2001, pp. 2316-2324
Background. Peritoneal fibrosis (PF) is one of the most serious complicatio
ns after long-term continuous ambulatory peritoneal dialysis (CAPD). Prolif
eration of human peritoneal mesothelial cells (HPMC) and matrix over-produc
tion are regarded as the main processes predisposing to PF. Dipyridamole (D
P) has been reported to have potential as an antiproliferative and antifibr
otic agent. We thus investigated the effect of DP in inhibiting proliferati
on and collagen synthesis of HPMC. A rat model of peritonitis-induced PF wa
s also established to demonstrate the in vivo preventive effect of DP.
Methods. HPMC was cultured from human omentum by an enzyme digestion method
. Cell proliferation was measured by the methyltetrazolium assay. Intracell
ular cAMP was measured using an enzyme immunoassay (EIA) kit. Total collage
n syn thesis was measured by H-3-proline incorporation assay. Expression of
collagen alpha1 (I) and collagen alpha1 (III) mRNAs was deter mined by Nor
thern blotting. The rat model of peritonitis-induced PF was developed by ad
ding dextran microbeads (Cytodex, 8 mg/1 mL volume) to a standardized suspe
nsion (3 x 10(9)) of Staphylococcus aureus. DP was administrated via intrav
enous infusion (4 mg in 1 h) daily for seven days. Macroscopic grading of i
ntraperitoneal adhesions and histological analyses of peritoneal thickness
and collagen expression were performed.
Results. Addition of DP to HPMC cultures suppressed serum-stimulated cell p
roliferation and collagen synthesis. The antimitogenic and antifibrotic eff
ects of DP appear to be predominantly mediated through the cAMP pathway. as
DP increased intracellular cAMP in a dose-dependent manner. The macroscopi
c grade of intraperitoneal adhesion and peritoneal thickness were both sign
ificantly increased in animals treated with Cytodex plus S. aureus: on the
other hand. DP attenuated these fibrotic changes with statistical significa
nce (P < 0.01). Analysis of gene expression of collagen <alpha>1 (I) and al
pha1 (III) in the peritoneal tissue of experimental animals yielded similar
results.
Conclusions. This study suggests that dipyridamole may have therapeutic pot
ential in treating peritoneal fibrosis.